Dan Becker

Dan Becker serves as the Managing Director of Access Biotechnology at Access Industries since August 2019, focusing on biopharma investments across various therapeutic areas. Dan is a board member at ACELYRIN, INC., which went public in May 2023, and has held board positions at several other companies, including Mariana Oncology, acquired by Novartis for up to $1.75 billion, and Day One Biopharmaceuticals, which had its IPO in May 2021. Previously, Dan contributed to the success of various companies through board roles, achieving notable acquisitions by major pharmaceutical firms such as Merck and Sanofi. Dan's prior experience includes positions at New Leaf Venture Partners and The Boston Consulting Group, specializing in healthcare and pharma R&D. Educational qualifications include an MD from the University of Michigan Medical School, a PhD in Cellular and Molecular Biology from the University of Michigan, and a BS in Physiology from the University of Illinois Urbana-Champaign.